Fiona E. Smyth
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Oncology top 5%
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 15
- Radiopharmaceutical Chemistry and Applications 11
- Oncology 19
- HER2/EGFR in Cancer Research 9
- CAR-T cell therapy research 8
- Co-authors
- Andrew M. Scott (32 shared papers)Martin W. Brechbiel (13 shared papers)Lloyd J. Old (14 shared papers)Antony W. Burgess (7 shared papers)Edouard C. Nice (5 shared papers)Marcus P. Kelly (5 shared papers)Terrance G. Johns (7 shared papers)Fook-Thean Lee (7 shared papers)
- Journals
- Clinical Cancer Research (4 papers)Journal of Clinical Oncology (3 papers)Gene Therapy (2 papers)Frontiers in Environmental Science (2 papers)Growth Factors (1 paper)
- Partner nations
- AustraliaUnited StatesBelgium
In The Last Decade
Fiona E. Smyth
37 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 96
- Radiology, Nuclear Medicine and Imaging 608
- Oncology 581
- Immunology 242
- Molecular Biology 519
- Genetics 55
Countries citing papers authored by Fiona E. Smyth
This map shows the geographic impact of Fiona E. Smyth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiona E. Smyth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiona E. Smyth more than expected).
Fields of papers citing papers by Fiona E. Smyth
This network shows the impact of papers produced by Fiona E. Smyth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiona E. Smyth. The network helps show where Fiona E. Smyth may publish in the future.
Co-authors
The 25 scholars most cited alongside Fiona E. Smyth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 121 | |
| 2 | 2002 | 116 | |
| 3 | 2010 | 100 | |
| 4 | 2005 | 73 | |
| 5 | Immuno-PET of human colon xenograft- bearing BALB/c nude mice using 124I-CDR-grafted humanized A33 monoclonal antibody. | 2001 | 66 |
| 6 | 2007 | 64 | |
| 7 | 2000 | 63 | |
| 8 | 2009 | 60 | |
| 9 | Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy. | 2000 | 52 |
| 10 | 2008 | 47 | |
| 11 | 1994 | 47 | |
| 12 | In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice. | 2000 | 46 |
| 13 | 2005 | 43 | |
| 14 | Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts. | 2001 | 37 |
| 15 | Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model. | 2001 | 37 |
| 16 | Enhanced efficacy of 90Y-radiolabeled anti-Lewis Y humanized monoclonal antibody hu3S193 and paclitaxel combined-modality radioimmunotherapy in a breast cancer model. | 2006 | 36 |
| 17 | 2008 | 33 | |
| 18 | 2007 | 30 | |
| 19 | Expression and targeting of human fibroblast activation protein in a human skin/severe combined immunodeficient mouse breast cancer xenograft model. | 2003 | 29 |
| 20 | 2001 | 26 |
About Fiona E. Smyth
Fiona E. Smyth is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, Immunology and Sociology and Political Science, having authored 39 papers that have together received 1.3k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (15 papers), Radiopharmaceutical Chemistry and Applications (11 papers), HER2/EGFR in Cancer Research (9 papers), CAR-T cell therapy research (8 papers), Glycosylation and Glycoproteins Research (6 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers), Immunotherapy and Immune Responses (4 papers) and Renal cell carcinoma treatment (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (608 citations), Oncology (581 citations), Immunology (242 citations), Molecular Biology (519 citations) and Genetics (55 citations). Fiona E. Smyth has collaborated with scholars based in Australia, United States and Belgium. Frequent co-authors include Andrew M. Scott, Martin W. Brechbiel, Lloyd J. Old, Antony W. Burgess, Edouard C. Nice, Marcus P. Kelly, Terrance G. Johns, Fook-Thean Lee, Cathrine Hall and Angela Rigopoulos. Their work appears in journals such as Clinical Cancer Research, Journal of Clinical Oncology, Gene Therapy, Frontiers in Environmental Science and Growth Factors.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.